# A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

> **NCT00545402** · PHASE4 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 180 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Mycophenolate mofetil, adjusted dose
- **DRUG:** Tacrolimus
- **DRUG:** Corticosteroids, IV
- **DRUG:** Mycophenolate mofetil, Standard dose
- **DRUG:** Corticosteroids, PO

## Key facts

- **NCT ID:** NCT00545402
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00545402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00545402, "A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00545402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*